Quality, access or efficiency? Proposals to fix SGR attempt to meet all three goals

The European Commission’s New Pharmaceutical Strategy for Europe

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know